Inventor · disambiguated record
Sing-Yuen Sit
Also filed as: SIT SING-YUEN
58 granted patents·7 pending applications·721 citations·filing 1988–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO34BRISTOL MYERS CO11VIIV HEALTHCARE UK NO 5 LTD7VIIV HEALTHCARE UK NO 4 LTD5REGUEIRO-REN ALICIA4
Top patents by PatentIndex Score
65 records- 0198US7449479B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 11, 2008·67 cites·16 claims
- 0298US6995174B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·194 cites·48 claims
- 0397US7915291B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 29, 2011·40 cites·21 claims
- 0493US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0593US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0693US8299094B2Hepatitis C virus inhibitorsWANG ALAN XIANGDONG·Filed 2010·Granted Oct 30, 2012·15 cites·11 claims
- 0793US6001836ADihydropyridine NPY antagonists: cyanoguanidine derivativesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Dec 14, 1999·98 cites·8 claims
- 0892US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 0992US8710229B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 29, 2014·10 cites·3 claims
- 1090US7772180B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·17 cites·20 claims
- 1189US8754068B2Modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Jun 17, 2014·15 cites·24 claims
- 1289US8748415B2C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2012·Granted Jun 10, 2014·16 cites·15 claims
- 1388US8906889B2C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 9, 2014·12 cites·19 claims
- 1488US8802661B2C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Aug 12, 2014·14 cites·22 claims
- 1585US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 1684US9227940B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·3 cites·2 claims
- 1784US6444675B24-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 3, 2002·14 cites·14 claims
- 1884US6391881B2Thiourea derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted May 21, 2002·13 cites·10 claims
- 1983US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 2083US8889871B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 18, 2014·3 cites·1 claims
- 2183US6562846B2Bisarylimidazolyl fatty acid amide hydrolase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 13, 2003·17 cites·20 claims
- 2281US6432960B2Squarate derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 13, 2002·15 cites·8 claims
- 2381US4897490AAntihypercholesterolemic tetrazole compoundsBRISTOL MYERS CO·Filed 1988·Granted Jan 30, 1990·27 cites·40 claims
- 2479US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2577US9636375B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 2, 2017·1 cites·1 claims
- 2677US6949574B2(Oxime)carbamoyl fatty acid amide hydrolase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 27, 2005·9 cites·21 claims
- 2776US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 2876US5110940AAntihypercholesterolemic tetrazole compoundsBRISTOL MYERS CO·Filed 1991·Granted May 5, 1992·15 cites·26 claims
- 2975US11464790B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Oct 11, 2022·0 cites·3 claims
- 3073US6177429B1Dihydropyrazine derivatives as NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jan 23, 2001·7 cites·7 claims
- 3172US8889854B2C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·1 cites·18 claims
- 3271US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 3370US5922735A4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Jul 13, 1999·22 cites·2 claims
- 3469US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 3567US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3667US5892045A4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Apr 6, 1999·19 cites·8 claims
- 3765US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 3863US6479482B2Alkylamine derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 12, 2002·2 cites·9 claims
- 3959US2014343000A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 4057US4870187AAntihypercholesterolemic tetrazol-1-yl compoundsBRISTOL MYERS CO·Filed 1988·Granted Sep 26, 1989·7 cites·11 claims
- 4156US7049309B23-Thia-4-arylquinolin-2-one potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 23, 2006·3 cites·8 claims
- 4256US4898949AIntermediates for the preparation of antihypercholesterolemic tetrazole compoundsBRISTOL MYERS CO·Filed 1988·Granted Feb 6, 1990·7 cites·24 claims
- 4355US12275721B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·12 claims
- 4454USRE39634EBisarylimidazoly fatty acid amide hydrolase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 15, 2007·0 cites·31 claims
- 4550US9249180B2C-3 alkyl and alkenyl modified betulinic acid derivativesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 2, 2016·0 cites·13 claims
- 4650US2016151387A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4749US7179920B23-thia-4-arylquinolin-2-one derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 20, 2007·0 cites·7 claims
- 4849US7091212B2Chiral dinapsolinePURDUE RESEARCH FOUNDATION·Filed 2002·Granted Aug 15, 2006·0 cites·4 claims
- 4949US2005131032A1(Oxime)carbamoyl fatty acid amide hydrolase inhibitorsFiled 2005·Application pending·0 cites
- 5048US12172975B21H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sing-Yuen Sit files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →